Nutra Pharma Corporation

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain.

Recent News

  • Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

    Plantation, Florida--(Newsfile Corp. - November 18, 2020) - Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is providing updates today on their work in using their technologies as potential countermeasures against nerve agents like sarin gas and VX.

    2020-11-18 9:15 AM ET
  • Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace

    Plantation, Florida--(Newsfile Corp. - November 11, 2020) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, has announced today that Nyloxin has been accepted to be listed on the Walmart Marketplace and is now available there for purchase."We've been working diligently with our retail partners t

    2020-11-11 7:15 AM ET
  • Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt

    Plantation, Florida--(Newsfile Corp. - November 4, 2020) -  Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their plans and progress involving financing, sales initiatives and the Company's efforts to eliminate toxic debt."Since 2015, a large amount of the stock di

    2020-11-04 9:00 AM ET
  • Nutra Pharma Provides Business and Compliance Updates

    Plantation, Florida--(Newsfile Corp. - November 3, 2020) - Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their plans and progress on improving Company transparency and public company compliance."Because of a variety of legal issues, business issues and the fallout fro

    2020-11-03 8:30 AM ET
  • Nutra Pharma Provides Updates on Marketing and Distribution

    Coral Springs, Florida--(Newsfile Corp. - March 3, 2020) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, provided updates today on their progress in the marketing and distribution of Nyloxin, Pet Pain-Away and Equine Pain-Away."We have been very busy in laying the groundwork for increasing brand awareness, online visibility...

    2020-03-03 8:30 AM ET